Missing/wrong data?
Log in to edit
PD2.02 (also presented as P1.44): Phase I/II Trial of X-396, a Novel ALK Inhibitor, in Patients With ALK+ NSCLC.
scientific article
Author/s
author: George R Blumenschein, Christine M. Lovly
Work details
Publication date
September 22, 2016
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.